Get the latest tech news
A Startup Has Unlocked a Way to Make Cheap Insulin
Houston-based rBIO has invented a new process to churn out insulin at higher yields using custom-made bacteria.
To do that, the company struck up a collaboration with Sergej Djuranovic, a professor of cell biology and physiology at Washington University School of Medicine in St. Louis. “New technologies that will make it even less expensive are certainly good, but they’re not going to be huge game changers right away,” says Robert Lash, a diabetes expert and chief medical officer of the Washington, DC-based Endocrine Society. Its product, R-biolin, is designed to be a copy of Novo Nordisk’s Novolin, an insulin that starts acting within 90 minutes and lasts for 24 hours.
Or read this on Wired
